Moran Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,598
Closed -$6.15M 437
2024
Q4
$6.15M Sell
23,598
-3,133
-12% -$930K 0.2% 141
2024
Q3
$8.61M Sell
26,731
-789
-3% -$258K 0.27% 119
2024
Q2
$8.6M Buy
27,520
+8,050
+41% +$2.36M 0.28% 119
2024
Q1
$5.54M Buy
+19,470
New +$5.7M 0.18% 157
2023
Q2
Sell
-988
Closed -$239K 382
2023
Q1
$239K Sell
988
-1,051
-52% -$258K 0.01% 341
2022
Q4
$536K Buy
+2,039
New +$547K 0.02% 294

Other funds holding AMGN

Moran Wealth Management's AMGN Position: Q1 2025 in Review

Moran Wealth Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 23,598 shares — an estimated $6.15M sold.

Moran Wealth Management first reported a position in AMGN in Q4 2022 and held it in 6 quarters. The position peaked at $8.61M in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Moran Wealth Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Moran Wealth Management sold 23,598 Amgen shares in Q1 2025, an estimated $6.15M.
  • Moran Wealth Management first reported a position in Amgen in Q4 2022 and held it in 6 quarters.
  • Moran Wealth Management's Amgen position peaked at $8.61M in Q3 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Moran Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.